Home/Filings/4/0001140361-14-010982
4//SEC Filing

Opexa Therapeutics, Inc. 4

Accession 0001140361-14-010982

CIK 0001069308operating

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 5:25 PM ET

Size

7.1 KB

Accession

0001140361-14-010982

Insider Transaction Report

Form 4
Period: 2014-02-28
Warma Neil K
President & CEO
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2014-02-28+316,250316,250 total
    Exercise: $1.82Exp: 2024-02-28Common Stock (316,250 underlying)
  • Award

    Common Stock

    2014-02-28+51,74897,634 total
Footnotes (2)
  • [F1]Vests in full on February 28, 2015.
  • [F2]25% excercisable on the one year anniversary of the date of grant with the balance vesting quarterly over the remaining three years.

Documents

1 file

Issuer

Opexa Therapeutics, Inc.

CIK 0001069308

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001069308

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:25 PM ET
Size
7.1 KB